Ro CEO on the next phase of the Ozempic boom

Since first appearing on the Masters of Scale podcast at the height of the Ozempic-Wegovy-Zepbound boom, Zach Reitano, CEO of Ro, has helped scale his company into a leading provider of branded GLP-1s—grabbing headlines with a 2026 Super Bowl ad featuring tennis champion Serena Williams and landing a major partnership with Novo Nordisk for the pill version of Wegovy. Now Reitano has new challenges to address: the long-term health unknowns of the medications, the cultural backlash to “Ozempic face,” and what this wave of disruption could mean not just for pharma but for the future of healthc...